[Federal Register Volume 64, Number 88 (Friday, May 7, 1999)]
[Notices]
[Page 24664]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-11316]



[[Page 24664]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration
[Docket No. 99N-1075]


Public Health Impact of Vibrio Parahaemolyticus in Molluscan 
Shellfish

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA), Center for Food Safety 
and Applied Nutrition, in conjunction with the Risk Assessment Working 
Group of the National Advisory Committee on Microbiological Criteria 
for Foods, in cooperation with the Food Safety and Inspection Service, 
U.S. Department of Agriculture (FSIS/USDA) is announcing a public 
meeting to discuss issues related to risk assessment models being 
developed to examine the relationship between Vibrio parahaemolyticus 
and human health.

DATE: The public meeting will be held on Wednesday, May 26, 1999, from 
8 a.m. to 5 p.m. Submit written notices of participation by May 20, 
1999. Written comments will be accepted until June 30, 1999.

ADDRESSES: The public meeting will be held at the Ambassador West 
Hotel, 1300 North State Parkway, Chicago, IL. Submit registration and 
written notices of participation to Catherine M. DeRoever (address 
below). Submit written comments to the Dockets Management Branch (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, 
Rockville, MD 20852. Two copies of any comments are to be submitted, 
except that individuals may submit one copy. Comments are to be 
identified with the docket number found in brackets in the heading of 
this document.

FOR FURTHER INFORMATION CONTACT: Catherine M. DeRoever, Executive 
Operations Staff (HFS-22), Center for Food Safety and Applied 
Nutrition, Food and Drug Administration, 200 C St., SW., Washington, DC 
20204, 202-205-4251, FAX 202-205-4970, or e-mail 
``[email protected]''.
    Those persons interested in attending the public meeting should, by 
May 20, 1999, fax their name, title, firm name, address, and telephone 
number to Catherine M. DeRoever (fax number above).
    Those persons interested in presenting information at the meeting 
should, by May 20, 1999, fax their name, title, firm name, address, 
telephone number, and an outline of their presentation to Catherine M. 
DeRoever (fax number above).
    There is no registration fee for this public meeting, but advance 
registration is suggested. Interested persons are encouraged to 
register early because space may be limited.

SUPPLEMENTARY INFORMATION: This public meeting will provide an 
opportunity for an open discussion of the issues related to risk 
assessment models under development that will be used to examine the 
relationship between V. parahaemolyticus and human health.
    The agenda will include presentations on such topics as: (1) 
Introduction to the risk assessment, (2) preharvest and harvest, (3) 
postharvest, (4) epidemiology of V. parahaemolyticus outbreaks, (5) 
consumption patterns, and (6) characteristics of V. parahaemolyticus 
dose-response.
    The sponsoring agencies encourage individuals with relevant 
scientific data or information, i.e., information concerning 
preharvesting, harvesting and postharvesting, epidemiology, exposure, 
and dose-response relationship of V. parahaemolyticus, to present such 
information at the meeting or in written comments to this record.
    A transcript of the public meeting will be prepared. Copies of the 
transcript may be requested in writing from the Freedom of Information 
Office (HFI-35), Food and Drug Administration, 5600 Fishers Lane, rm. 
12A-16, Rockville, MD 20857, approximately 15 working days after the 
meeting. The transcript of the public meeting and submitted comments 
will be available for public examination at the Dockets Mnagement 
Branch (address above) between 9 a.m. and 4 p.m., Monday through 
Friday.

    Dated: April 29, 1999.
William K. Hubbard,
Acting Deputy Commissioner for Policy.
[FR Doc. 99-11316 Filed 5-6-99; 8:45 am]
BILLING CODE 4160-01-F